Development and implementation of a pharmacist-managed clinical pharmacogenetics service. (Q35586019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Development and implementation of a pharmacist-managed clinical pharmacogenetics service (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alejandro R Molinelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kristine R Crews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

John N McCormick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Donald K Baker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Richard Mullins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mary V Relling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

James M Hoffman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

143-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

ASHP national survey of pharmacy practice in hospital settings: dispensing and administration--2008.

19 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacogenomics: challenges and opportunities

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Evidence of the economic benefit of clinical pharmacy services: 1996-2000.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacogenetics: the therapeutic drug monitoring of the future?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacogenetics of cancer therapy: getting personal

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Thiopurine methyltransferase in acute lymphoblastic leukemia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

Collaboration between pharmacy and laboratory: defining total allowable error limits for therapeutically monitored drugs.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228517

ASHP statement on the pharmacist's role in clinical pharmacokinetic monitoring

26 September 2018

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Polymorphisms and the Pocketbook: The Cost‐Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of Helicobacter pylori Infection Associated with Duodenal Ulcer

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Pharmacogenetics of opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Codeine, ultrarapid-metabolism genotype, and postoperative death

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100113

Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200062

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

AmpliChip CYP450 test

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200062

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Invader UGT1A1 molecular assay for irinotecan toxicity. A genetic test for an increased risk of toxicity from the cancer chemotherapy drug irinotecan (Camptosar)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21200062

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2146/AJHP100113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

21200062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21200062%20AND%20SRC:MED&resulttype=core&format=json